08/18/2014 - 12:47

A study from UT Southwestern researchers found that recently introduced cholesterol guidelines would significantly reduce new cardiovascular events, when compared to treatment based on previous cholesterol guidelines. The research identified Dallas Heart Study participants in the 30 to 65 age range who would have newly qualified for statin use under the new cholesterol guidelines introduced in 2013 by the American College of Cardiology (ACC) and the American Heart Association (AHA).


06/14/2014 - 20:54

A new study suggests that canola oil should be one of the oils of choice for people with Type 2 diabetes.Those on canola bread diet saw both a reduction in blood glucose levels and significant reduction in LDL cholesterol

04/30/2014 - 13:55

Numerous studies have suggested a relationship between cardiovascular disease risk factors and prostate cancer. A new study by researchers at the University of California, San Diego School of Medicine, with colleagues in Norway, significantly refines the association, highlighting genetic risk factors associated with low density lipoprotein (LDL) cholesterol and triglycerides as key players and identifying 17 related gene loci that make risk contributions to levels of these blood lipids and to prostate cancer.


03/17/2014 - 08:51

A gene termed TM6SF2 has been identified as important in affecting cholesterol levels and myocardial infarction in a new study published as an advanced online publication in Nature Genetics. The study, from scientists in Norway and in the University of Michigan offers a promising new drug target in cardiovascular disease.


02/28/2014 - 10:18

Early but not advanced forms of atherosclerotic plaques in the vessel wall disappear when the levels of ‘bad’ cholesterol are lowered, according to a study in mice from Karolinska Institutet, Sweden. The findings, published in  PLoS Genetics , indicate that preventative cholesterol-lowering treatment could prevent more advanced, clinically relevant plaque to develop.


12/09/2013 - 10:15

High-density lipoprotein (HDL), known colloquially as "good cholesterol", protects against dangerous deposits in the arteries. An important function of HDL is its anti-inflammatory properties. An international research team at the Institute of Innate Immunity at the University Hospital of Bonn and the LIMES Institute at the University of Bonn has identified a central switch by which HDL controls the inflammatory response. The results are presented in the current issue of "Nature Immunology".